Skip to content

The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer

An Individualised 8-week Remote Exercise Intervention to Improve QoL, Cardiometabolic Risk and Physical Activity Level in Men With Prostate Cancer Undergoing ADT Treatment.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05989854
Enrollment
50
Registered
2023-08-14
Start date
2024-04-01
Completion date
2025-06-30
Last updated
2024-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate cancer, Exercise, Online, Quality of Life

Brief summary

Currently, there are few opportunities for patients with cancer to have individual exercise guidance, and this has further been impacted by the Covid-19 pandemic. However, during the pandemic the use of virtual/remote platforms has been crucial in delivering care to cancer patients. The investigators think that remote exercise training may also offer a solution to support positive change in prostate cancer patients. As a result, the investigators have developed a remote/online exercise programme to explore this further. This study will explore the effectiveness of an 8-week remote exercise and behavioural support intervention, and whether prostate cancer patients feel they benefit from this. The study also aims to see if this sort of exercise programme can be delivered to more prostate cancer patients in the future. This project is open to men with prostate cancer on long term hormone therapy. The intervention will be comprised of one remote supervised session per week, completed 1-1 using an online platform and up to two additional sessions, depending on its suitability for the patient, will be prescribed as unsupervised home-based exercise.

Interventions

BEHAVIORALExercise

8 week exercise intervention, 3x/wk

Sponsors

Royal Surrey County Hospital NHS Foundation Trust
CollaboratorOTHER
University of Surrey
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Have had an orchiectomy OR; * Are receiving a GnRH agonist/antagonist OR; * Are currently receiving Abiraterone, Enzalutamide, Apalutamide or Darolutamide * Long-term retention is planned (intending to remain on the above stated treatments for at least the next 6 months).

Exclusion criteria

* Patients who are currently classed as in active treatment i.e. are currently receiving chemotherapy/radiation therapy (Note: Patients that are included in the study but after inclusion are moved onto chemo/radiation therapy, will still be able to participate in the project). * Patients who are stratified as high risk for having a cardiovascular event. * Acute illness; or any musculoskeletal, cardiovascular or neurological disorder that could inhibit or put them at risk from exercising, as determined by screening and their clinician. * Men with painful or unstable bony metastases.

Design outcomes

Primary

MeasureTime frameDescription
Functional Assessment of Cancer Therapy-Prostatet= 0, 4, 8, 16 & 30 weeksFunctional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire. Twenty-seven questions about physical, social/family, emotional and functional well-being are graded from 0-4 (0 = not at all; 4 = very much), yielding a total between 0 and 108.
Functional Assessment of Cancer Therapyt= 0, 4, 8, 16 & 30 weeksFunctional Assessment of Cancer Therapy fatigue (FACIT-f) questionnaire. The FACIT-Fatigue is a validated questionnaire that was originally developed for the precise evaluation of fatigue levels in cancer patients with anemia. It consists of 13 questions using a 5 point scale (0=not at all; 1 = a little bit, 2 = somewhat, 3 = quite a bit and 4 = very much). It has been used frequently in the clinical trial setting (please see appendix 1). Responses to each question are added with equal weight to obtain a total score. The range of possible scores is 0-52, with 0 corresponding to the highest level of fatigue and 52 corresponding to the lowest level of fatigue.

Secondary

MeasureTime frameDescription
Cardiovascular riskt= 0, 4, 8 weeksQrisk3. Estimation of cardiovascular risk based on demographical and physiological parameters
Leisure time physical activityt= 0, 4, 8, 16 & 30 weeksGodin Leisure Time Exercise Questionnaire. This is a 3 question self-report questionnaire - indirect measure of physical activity
Health statust= 0, 4, 8, 16 & 30 weekseq-5d-5l. It comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels: no problems, slight problems, some problems, severe problems and unable to do. Each level of answer consists of each level of score ranges from 1 to 5. Each participant will have a health status consisting of 5 digits. Using the set of weights from Vietnamese population provided from the EuroGroup, we can convert each EQ-5D health state into a single summary index value. The index value ranges from 0 to 1, higher scores meaning better health quality.
Exercise adherenceweekly for 8 weeksSession adherence. The number of sessions attended, and % of scheduled sessions performed. Every exercise session either completed or not completed over the 8 week intervention period
Physical activityt= 0, 4, 8, 16 & 30 weeksThe Dukes Activity Status Index. The Duke Activity Status Index (DASI) is a 12-item questionnaire that utilized self-reported physical work capacity to estimate peak metabolic equivalents (METs).

Countries

United Kingdom

Contacts

Primary ContactRalph Manders, PhD
r.manders@surrey.ac.uk+44(0)1483688668

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026